1. 3434 A UK national phase I/II clinical trial of a MEK1/2 inhibitor combined with highly active anti-retroviral therapy for HIV-associated Kaposi's sarcoma. (September 2015) Authors: Young, R.; Poyser, C.; Crack, L.; Dockrell, D.; Bowman, C.; Billingham, L.; Bower, M.; Westwell, S.; Leahy, M.; Woll, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S699 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Real-world Analysis of the Treatment of HER2+ Metastatic Breast Cancer (mBC) Beyond First-line HER2-directed Therapies. Issue 7 (July 2019) Authors: DeSouza, K.; Zammit, R.; Bloomfield, D.; Simcock, R.; Sinha, R.; Westwell, S.; Moss, C.; Moss, A.; Sham, J.; Patel, G. Journal: Clinical oncology Issue: Volume 31:Issue 7(2019) Page Start: e108 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Sussex-wide Immunotherapy Toxicity Service to Optimise Patient Care and Redistribute Workload from Tumour-specific Oncologists. (March 2022) Authors: Cheung, L.; Mackay, K.; Petrovics, E.; Appleyard, S.; Hodge, A.; Marrazes, C.; Westwell, S. Journal: Clinical oncology Issue: Volume 34(2022)Supplement 1 Page Start: e10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Defining the Older Patient Population (>65 Years) Treated for Metastatic Breast Cancer (mBC) Within the Sussex Cancer Network. Issue 6 (June 2018) Authors: DeSouza, K.; Zammit, R.; Simpson, L.; Watson, L.; Bracewell, K.; Whitfield, C.; Bloomfield, D.; Simcock, R.; Sinha, R.; Westwell, S.; Moss, C.; Moss, A.; Sham, J.; Patel, G. Journal: Clinical oncology Issue: Volume 30:Issue 6(2018) Page Start: e43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗